← Leaderboards
Nhat-Tu Le
University Of Tx Md Anderson Can Ctr
$3,369,101
Attributed
$7,394,727
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,394,727 · 3
By mechanism
R01$7,394,727 · 3
Top collaborators
- Jun-Ichi Abe7 shared
- John P Cooke7 shared
- Craig N Morrell4 shared
- Bing Yu3 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- John P Cooke$32,967,803
- Jun-Ichi Abe$17,528,597
- Michael W Andreeff$17,991,896
- Sadhan Majumder$10,510,614
- Hui-Lin Pan$27,634,836
Others in their field
Other Emerging Leaders on “Event”
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ted Ross · University Of Georgia$70,992,558
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Olwen Hahn · Brigham And Women'S Hospital$36,805,199
Research focus
EventApoptosisPlayMolecularPhenotypeFunctional DisorderPathway InteractionsMediatingNovel Therapeutic InterventionPhosphotransferasesEndothelial CellsSignal PathwayKnock-OutLinkPhosphorylationSignal TransductionInflammationArterial Fatty StreakComplexBindingKnock-In MouseMapk7 GeneProteinsTumor Suppressor Proteins
Grant awards (12)
Premature aging disorders, metabolites, and atherosclerosis$712,298
R01 · FY2025 · HL
Premature aging disorders, metabolites, and atherosclerosis$704,737
R01 · FY2024 · HL
Premature aging disorders, metabolites, and atherosclerosis$756,681
R01 · FY2023 · HL
Pathological flow-induced endothelial damage and plaque erosion$782,390
R01 · FY2022 · HL
Pathological flow-induced endothelial damage and plaque erosion$788,251
R01 · FY2021 · HL
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation$380,587
R01 · FY2021 · HL · contact PI
Pathological flow-induced endothelial damage and plaque erosion$793,939
R01 · FY2020 · HL
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation$380,587
R01 · FY2020 · HL · contact PI
Pathological flow-induced endothelial damage and plaque erosion$829,206
R01 · FY2019 · HL
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation$380,587
R01 · FY2019 · HL · contact PI
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation$395,962
R01 · FY2018 · HL · contact PI
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation$489,502
R01 · FY2017 · HL · contact PI